Vilsbøll, T: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes

Hædersdal, Sofie, Lund, Asger, Knop, Filip K., Vilsbøll, Tina

Journal:

Mayo Clinic Proceedings

Year:

2018

Language:

english

File:

PDF, 1.02 MB

english, 2018

2

The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

Heimbürger, Sebastian M., Brønden, Andreas, Johansen, Nicklas J., Dejgaard, Thomas F., Vilsbøll, Tina, Knop, Filip K.

Journal:

Expert Opinion on Pharmacotherapy

Year:

2019

Language:

english

File:

PDF, 1016 KB

english, 2019

3

Glucagon-like peptide 1 in health and disease

Andersen, Andreas, Lund, Asger, Knop, Filip K., Vilsbøll, Tina

Journal:

Nature Reviews Endocrinology (formerly Nature Clinical Practice Endocrinology & Metabolism)

Year:

2018

Language:

english

File:

PDF, 2.62 MB

english, 2018

4

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

T. Vilsbøll, J. Rosenstock, H. Yki-Järvinen, W. T. Cefalu, Y. Chen, E. Luo, B. Musser, P. J. Andryuk, Y. Ling, K. D. Kaufman, J. M. Amatruda, S. S. Engel, L. Katz

Journal:

Diabetes, Obesity and Metabolism

Year:

2010

Language:

english

File:

PDF, 574 KB

english, 2010

5

The effect of glucagon-like peptide 1 on cardiovascular risk

Sivertsen, Jacob, Rosenmeier, Jaya, Holst, Jens J., Vilsbøll, Tina

Journal:

Nature Reviews Cardiology (formerly Nature Clinical Practice Cardiovascular Medicine)

Year:

2012

Language:

english

File:

PDF, 1.72 MB

english, 2012

6

Glucagon and the gut hormones GLP-1 and oxyntomodulin increase resting energy expenditure in man

J. Bagger, J. Holst, Tina Vilsbøll, Filip K. Knop

Journal:

Regulatory Peptides

Year:

2012

Language:

english

File:

PDF, 78 KB

english, 2012

7

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

F. K. Knop, K. Aaboe, T. Vilsbøll, A. Vølund, J. J. Holst, T. Krarup, S. Madsbad

Journal:

Diabetes, Obesity and Metabolism

Year:

2012

Language:

english

File:

PDF, 986 KB

english, 2012

8

The incretin system and its role in type 2 diabetes mellitus

Jens Juul Holst, Tina Vilsbøll, Carolyn F. Deacon

Journal:

Molecular and Cellular Endocrinology

Year:

2009

Language:

english

File:

PDF, 597 KB

english, 2009

9

Evaluation of beta-cell secretory capacity using glucagon-like peptide 1

Vilsboll, T., Toft-Nielsen, M. B., Krarup, T., Madsbad, S., Dinesen, B., Holst, J. J.

Journal:

Year:

2000

Language:

english

File:

PDF, 91 KB

english, 2000

10

Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes: Systematic review and meta-analysis of clinical studies

Calanna, S., Christensen, M., Holst, J. J., Laferrere, B., Gluud, L. L., Vilsboll, T., Knop, F. K.

Journal:

Year:

2013

Language:

english

File:

PDF, 499 KB

english, 2013

11

Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes

Christensen, Mikkel, Calanna, Salvatore, Sparre-Ulrich, Alexander H., Kristensen, Peter L., Rosenkilde, Mette M., Faber, Jens, Purrello, Francesco, van Hall, Gerrit, Holst, Jens J., Vilsbøll, Tina, Kn

Journal:

Year:

2015

Language:

english

File:

PDF, 987 KB

english, 2015

12

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Vilsboll, T., Krarup, T., Deacon, C. F., Madsbad, S., Holst, J. J.

Journal:

Year:

2001

Language:

english

File:

PDF, 92 KB

english, 2001

13

Alcohol consumption among patients with diabetes: a survey-based cross-sectional study of Danish adults with diabetes

Jakobsen, M. L., Larsen, J. R., Glu mer, C., Juel, K., Ekholm, O., Vilsboll, T., Becker, U., Fink-Jensen, A.

Journal:

Scandinavian Journal of Public Health

Year:

2016

Language:

english

File:

PDF, 456 KB

english, 2016

14

Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

Grøndahl, Magnus F., Keating, Damien J., Vilsbøll, Tina, Knop, Filip K.

Journal:

Current Diabetes Reports

Year:

2017

Language:

english

File:

PDF, 1.07 MB

english, 2017

15

FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest

Søberg, Susanna, Andersen, Emilie S., Dalgaard, Niels B., Jarlhelt, Ida, Hansen, Nina L., Hoffmann, Nina, Vilsbøll, Tina, Chenchar, Anne, Jensen, Michal, Grevengoed, Trisha J., Trammell, Sam A.J., Kno

Journal:

Molecular Metabolism

Year:

2018

Language:

english

File:

PDF, 544 KB

english, 2018

16

Is glucagon-like peptide-1 fully protected by dipeptidyl peptidase 4 inhibitor administration in patients with type 2 diabetes?

Andersen, E. S., Lund, A., Bagger, J. I., Andreasen, C., Grøndahl, M. F., Deacon, C. F., Hartmann, B., Holst, J. J., Knop, F. K., Vilsbøll, Tina

Journal:

Diabetes, Obesity and Metabolism

Year:

2018

Language:

english

File:

PDF, 1.14 MB

english, 2018

17

Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis

Siskind, Dan, Hahn, Margaret, Correll, Christoph U., Fink-Jensen, Anders, Russell, Anthony W., Bak, Nikolaj, Broberg, Brian V., Larsen, Julie, Ishøy, Pelle L., Vilsbøll, Tina, Knop, Filip K., Kisely,

Journal:

Diabetes, Obesity and Metabolism

Year:

2018

Language:

english

File:

PDF, 1006 KB

english, 2018

18

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

Demant, Mia, Bagger, Jonatan I., Suppli, Malte P., Lund, Asger, Gyldenløve, Mette, Hansen, Katrine B., Hare, Kristine J., Christensen, Mikkel, Sonne, David P., Holst, Jens J., Vilsbøll, Tina, Knop, Fi

Journal:

Metabolic Syndrome and Related Disorders

Year:

2018

Language:

english

File:

PDF, 195 KB

english, 2018

19

Semaglutide Treatment and Renal Function in the SUSTAIN 6 Trial

Hramiak, Irene, Vilsbøll, Tina, Gumprecht, Janusz, Silver, Robert, Hansen, Thomas, Pettersson, Jonas, Wilding, John

Journal:

Canadian Journal of Diabetes

Year:

2018

Language:

english

File:

PDF, 413 KB

english, 2018

20

How should thyroid-related quality of life be assessed? Recalled patient-reported outcomes compared with here-and-now measures

Boesen, Victor Brun, Feldt-Rasmussen, Ulla, Bjorner, Jakob Bue, Cramon, Per, Groenvold, Mogens, Nygaard, Birte, Rasmussen, Åse Krogh, Vilsbøll, Tina, Watt, Torquil

Journal:

Year:

2018

Language:

english

File:

PDF, 2.92 MB

english, 2018

21

The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to dietary self-management in patients with type 1 diabetes

Ewers, Bettina, Vilsbøll, Tina, Andersen, Henrik Ullits, Bruun, Jens Meldgaard

Journal:

Year:

2019

Language:

english

File:

PDF, 640 KB

english, 2019

22

Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People

Shadid, Samyah, Abosi-Appeadu, Kessewa, De Maertelaere, Anne-Sophie, Defreyne, Justine, Veldeman, Laurens, Holst, Jens J., Lapauw, Bruno, Vilsbøll, Tina, T’Sjoen, Guy

Journal:

Year:

2019

Language:

english

File:

PDF, 871 KB

english, 2019

23

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

Bergmann, Natasha C., Gasbjerg, Lærke S., Heimbürger, Sebastian M., Krogh, Liva S.L., Dela, Flemming, Hartmann, Bolette, Holst, Jens J., Jessen, Lene, Christensen, Mikkel B., Vilsbøll, Tina, Lund, Asg

Journal:

Year:

2020

Language:

english

File:

PDF, 934 KB

english, 2020

24

No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

T. Vilsbøll, T. Krarup, S. Madsbad, J. J. Holst

Journal:

Diabetic Medicine

Year:

2001

Language:

english

File:

PDF, 100 KB

english, 2001

25

19th Anglo–Danish–Dutch Diabetes Group meeting

E. J. P. De Koning, T. Vilsboll, F. Dela

Journal:

Diabetic Medicine

Year:

2002

Language:

english

File:

PDF, 86 KB

english, 2002

26

Incretins, insulin secretion and Type 2 diabetes mellitus

T. Vilsbøll, J. J. Holst

Journal:

Year:

2004

Language:

english

File:

PDF, 173 KB

english, 2004

27

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

F. K. Knop, T. Vilsbøll, S. Madsbad, J. J. Holst, T. Krarup

Journal:

Year:

2007

Language:

english

File:

PDF, 307 KB

english, 2007

28

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

P. V. Højberg, M. Zander, T. Vilsbøll, F. K. Knop, T. Krarup, A. Vølund, J. J. Holst, S. Madsbad

Journal:

Year:

2008

Language:

english

File:

PDF, 227 KB

english, 2008

29

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

P. V. Højberg, T. Vilsbøll, R. Rabøl, F. K. Knop, M. Bache, T. Krarup, J. J. Holst, S. Madsbad

Journal:

Year:

2009

Language:

english

File:

PDF, 201 KB

english, 2009

30

The T allele of rs7903146TCF7L2is associated with impaired insulinotropic action of incretin hormones, reduced 24

K. Pilgaard, C. B. Jensen, J. H. Schou, V. Lyssenko, L. Wegner, C. Brøns, T. Vilsbøll, T. Hansen, S. Madsbad, J. J. Holst, A. Vølund, P. Poulsen, L. Groop, O. Pedersen, A. A. Vaag

Journal:

Year:

2009

Language:

english

File:

PDF, 288 KB

english, 2009

31

Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

Dario Giugliano, Eberhard Standl, Tina Vilsbøll, John Betteridge, Riccardo Bonadonna, Ian W. Campbell, Gerit-Holger Schernthaner, Bart Staels, Antonia Trichopoulou, Eduardo Farinaro

Journal:

Acta Diabetologica

Year:

2009

Language:

english

File:

PDF, 226 KB

english, 2009

32

Electroretinography in healthy subjects in relation to systemic glucocorticoid intake

Per Kappelgaard, Katrine B. Hansen, Tina Vilsbøll, Filip K. Knop, Michael Larsen

Journal:

Documenta Ophthalmologica

Year:

2012

Language:

english

File:

PDF, 229 KB

english, 2012

33

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

M. Horowitz, T. Vilsbøll, M. Zdravkovic, M. Hammer, S. Madsbad

Journal:

Diabetes, Obesity and Metabolism

Year:

2008

Language:

english

File:

PDF, 263 KB

english, 2008

34

The effects of glucagon-like peptide-1 on the beta cell

Journal:

Diabetes, Obesity and Metabolism

Year:

2009

Language:

english

File:

PDF, 245 KB

english, 2009

35

Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus

K. Aaboe, F. K. Knop, T. Vilsbøll, C. F. Deacon, J. J. Holst, S. Madsbad, T. Krarup

Journal:

Diabetes, Obesity and Metabolism

Year:

2010

Language:

english

File:

PDF, 838 KB

english, 2010

36

Glucagon antagonism as a potential therapeutic target in type 2 diabetes

J. I. Bagger, F. K. Knop, J. J. Holst, T. Vilsbøll

Journal:

Diabetes, Obesity and Metabolism

Year:

2011

Language:

english

File:

PDF, 567 KB

english, 2011

37

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

T. Vilsbøll, B. Brock, H. Perrild, K. Levin, H.-H. Lervang, K. Kølendorf, T. Krarup, O. Schmitz, M. Zdravkovic, T. Le-Thi, S. Madsbad

Journal:

Diabetic Medicine

Year:

2008

Language:

english

File:

PDF, 185 KB

english, 2008

38

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

J.-P. Courrèges, T. Vilsbøll, M. Zdravkovic, T. Le-Thi, T. Krarup, O. Schmitz, R. Verhoeven, I. Bugáñová, S. Madsbad

Journal:

Diabetic Medicine

Year:

2008

Language:

english

File:

PDF, 370 KB

english, 2008

39

Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes

P. V. Højberg, T. Vilsbøll, M. Zander, F. K. Knop, T. Krarup, A. Vølund, J. J. Holst, S. Madsbad

Journal:

Diabetic Medicine

Year:

2008

Language:

english

File:

PDF, 228 KB

english, 2008

40

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

K. B. Hansen, F. K. Knop, J. J. Holst, T. Vilsbøll

Journal:

International Journal of Clinical Practice

Year:

2009

Language:

english

File:

PDF, 119 KB

english, 2009

41

Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption

Dennis B Henriksen, Peter Alexandersen, Nina H Bjarnason, Tina Vilsbøll, Bolette Hartmann, Eva EG Henriksen, Inger Byrjalsen, Thure Krarup, Jens J Holst, Claus Christiansen

Journal:

Journal of Bone and Mineral Research

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

42

Lixisenatide for type 2 diabetes mellitus

Christensen, Mikkel, Knop, Filip K, Vilsbøll, Tina, Holst, Jens J

Journal:

Expert Opinion on Investigational Drugs

Year:

2011

Language:

english

File:

PDF, 251 KB

english, 2011

43

Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis

F.K. Knop, T. Vilsbøll, S. Larsen, S. Madsbad, J.J. Holst, T. Krarup

Journal:

Regulatory Peptides

Year:

2010

Language:

english

File:

PDF, 865 KB

english, 2010

44

Reduced incretin effect in truncally vagotomized subjects

A. Plamboeck, S. Veedfald, C.F. Deacon, A. Wettergren, L.B. Svendsen, S. Meisner, C. Hovendal, J.J. Holst, F. Knop, T. Vilsbøll

Journal:

Regulatory Peptides

Year:

2012

Language:

english

File:

PDF, 86 KB

english, 2012

45

The effect of GLP-1 on food intake is lost in trunkally vagotomized subjects

A. Plamboeck, S. Veedfald, C.F. Deacon, A. Wettergren, L.B. Svendsen, S. Meisner, C. Hovendal, J.J. Holst, T. Vilsbøll, F. Knop

Journal:

Regulatory Peptides

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

46

Acute dipeptidyl peptidase 4 inhibition has no impact on the incretin effect, glucose tolerance or gastric emptying in healthy subjects

N. Rhee, S. Østoft, T. Vilsbøll, F. Knop

Journal:

Regulatory Peptides

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

47

Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes

N. A. Rhee, T. Vilsbøll, F. K. Knop

Journal:

Diabetes, Obesity and Metabolism

Year:

2012

Language:

english

File:

PDF, 534 KB

english, 2012

48

Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide

T. Vilsbøll, A. J. Garber

Journal:

Diabetes, Obesity and Metabolism

Year:

2012

Language:

english

File:

PDF, 647 KB

english, 2012

49

Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings

J. J. Holst, T. Vilsbøll

Journal:

Diabetes, Obesity and Metabolism

Year:

2012

Language:

english

File:

PDF, 590 KB

english, 2012

50

Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?

Annesofie Faurschou, Claus Zachariae, Lone Skov, Tina Vilsbøll, Filip K. Knop

Journal:

Medical Hypotheses

Year:

2011

Language:

english

File:

PDF, 223 KB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски